Market Overview:
The global DNA polymerase market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for DNA polymerases in hospitals, biopharmaceutical companies, academic and research institutes, and others. North America is expected to dominate the global DNA polymerase market during the forecast period owing to the presence of major players in this region and technological advancements. Asia Pacific is projected to be the fastest-growing region during the forecast period owing to rising investments by key players in this region and growing awareness about genetic disorders.
Product Definition:
DNA polymerase is an enzyme that helps to create new DNA molecules by catalyzing the joining of nucleotides, the building blocks of DNA. It is essential for replication and repair of DNA.
Prokaryotic DNA Polymerase:
Prokaryotic DNA polymerase is used for the addition of nucleotides to the 3' end of DNA. It is a type of enzyme known as topoisomerase which has broad specificity in terms of adding both purine- and pyrimidine-based nucleotides to various substrates such as single-stranded, linear duplexes, and hairpin loops. Prokaryotic enzymes are utilized by E.
Eukaryotic DNA Polymerase:
Eukaryotic DNA polymerase is a type of enzyme that catalyzes the addition of nucleotides to the growing DNA chain. The process of adding nucleotides to the nascent chain is known as transcription. Eukaryotic polymerases are characterized by having a larger substrate-specificity than bacterial enzymes and they also operate at higher temperatures.
Application Insights:
The academic and research institutes segment held the largest revenue share of over 40% in 2017. This is attributed to the presence of a large number of researchers working on molecular biology, cell biology, and other related fields. DNA polymerase is used for various applications in genetic engineering including recombinant DNA technology. Various companies are involved in R&D activities to develop new products that can be used specifically in academic and research institutes as well as hospitals.
DNA polymerase finds wide application scope within biopharmaceutical companies for drug development purposes owing to its ability to catalyze multiple elongation & proofreading steps with high fidelity during PCR amplification process (Polymerase Chain Reaction). Increasing demand for rapid diagnosis through Polymerase Chain Reaction (PCR) techniques coupled with growing need for quality control procedures during clinical trials are some factors driving product demand from this sector at a significant level.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biopharmaceutical companies and academic & research institutes involved in drug discovery activities is expected to drive the demand for polymerases from these regions. Moreover, increasing government funding for R&D activities pertaining to infectious diseases and cancer is anticipated to propel product demand over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure, rising awareness regarding genetic tests, growing investment by pharmaceutical companies in this region coupled with favorable regulations aimed at promoting innovation that are likely boost industry growth.
Growth Factors:
- Increasing demand for DNA sequencing services due to the rise in research and development activities in the life sciences sector.
- Growing number of genetic disorders and increasing awareness about their diagnosis and treatment is expected to drive the demand for DNA polymerase enzymes over the forecast period.
- Rising application of polymerase chain reaction (PCR) technology in clinical diagnostics is anticipated to boost the growth of DNA polymerase market during the forecast period.
- Increasing use of PCR-based assays for detection of foodborne pathogens is projected to fuel growth of global DNA polymerase market during 2016-2024
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Polymerase Market Research Report
By Type
Prokaryotic DNA Polymerase, Eukaryotic DNA Polymerase
By Application
Hospitals, Biopharmaceutical Companies, Academic and Research Institutes, Others
By Companies
Roche, Qiagen, Merck, Illumina, Thermo Fisher Scientific, Agilent Technologies, New England Biolabs, Promega Corporation, Takara Bio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global DNA Polymerase Market Report Segments:
The global DNA Polymerase market is segmented on the basis of:
Types
Prokaryotic DNA Polymerase, Eukaryotic DNA Polymerase
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Biopharmaceutical Companies, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Qiagen
- Merck
- Illumina
- Thermo Fisher Scientific
- Agilent Technologies
- New England Biolabs
- Promega Corporation
- Takara Bio
Highlights of The DNA Polymerase Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prokaryotic DNA Polymerase
- Eukaryotic DNA Polymerase
- By Application:
- Hospitals
- Biopharmaceutical Companies
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Polymerase Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA polymerase is an enzyme that catalyzes the synthesis of DNA from deoxyribonucleotides.
Some of the major companies in the dna polymerase market are Roche, Qiagen, Merck, Illumina, Thermo Fisher Scientific, Agilent Technologies, New England Biolabs, Promega Corporation, Takara Bio.
The dna polymerase market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA Polymerase Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DNA Polymerase Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DNA Polymerase Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DNA Polymerase Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DNA Polymerase Market Size & Forecast, 2018-2028
4.5.1 DNA Polymerase Market Size and Y-o-Y Growth
4.5.2 DNA Polymerase Market Absolute $ Opportunity
Chapter 5 Global DNA Polymerase Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 DNA Polymerase Market Size Forecast by Type
5.2.1 Prokaryotic DNA Polymerase
5.2.2 Eukaryotic DNA Polymerase
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global DNA Polymerase Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 DNA Polymerase Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Biopharmaceutical Companies
6.2.3 Academic and Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA Polymerase Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA Polymerase Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America DNA Polymerase Analysis and Forecast
9.1 Introduction
9.2 North America DNA Polymerase Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America DNA Polymerase Market Size Forecast by Type
9.6.1 Prokaryotic DNA Polymerase
9.6.2 Eukaryotic DNA Polymerase
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America DNA Polymerase Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Biopharmaceutical Companies
9.10.3 Academic and Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe DNA Polymerase Analysis and Forecast
10.1 Introduction
10.2 Europe DNA Polymerase Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe DNA Polymerase Market Size Forecast by Type
10.6.1 Prokaryotic DNA Polymerase
10.6.2 Eukaryotic DNA Polymerase
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe DNA Polymerase Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Biopharmaceutical Companies
10.10.3 Academic and Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific DNA Polymerase Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific DNA Polymerase Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific DNA Polymerase Market Size Forecast by Type
11.6.1 Prokaryotic DNA Polymerase
11.6.2 Eukaryotic DNA Polymerase
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific DNA Polymerase Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Biopharmaceutical Companies
11.10.3 Academic and Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America DNA Polymerase Analysis and Forecast
12.1 Introduction
12.2 Latin America DNA Polymerase Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America DNA Polymerase Market Size Forecast by Type
12.6.1 Prokaryotic DNA Polymerase
12.6.2 Eukaryotic DNA Polymerase
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America DNA Polymerase Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Biopharmaceutical Companies
12.10.3 Academic and Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) DNA Polymerase Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) DNA Polymerase Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) DNA Polymerase Market Size Forecast by Type
13.6.1 Prokaryotic DNA Polymerase
13.6.2 Eukaryotic DNA Polymerase
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) DNA Polymerase Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Biopharmaceutical Companies
13.10.3 Academic and Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA Polymerase Market: Competitive Dashboard
14.2 Global DNA Polymerase Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Qiagen
14.3.3 Merck
14.3.4 Illumina
14.3.5 Thermo Fisher Scientific
14.3.6 Agilent Technologies
14.3.7 New England Biolabs
14.3.8 Promega Corporation
14.3.9 Takara Bio
